Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Infibond (later rebranded as Infi) was an Israeli technology company that developed an advanced Artificial Intelligence platform based on a proprietary concept called "Artificial Psychology." The company's technology was designed to analyze human personality traits, emotional states, and cognitive patterns to provide deep psychological insights and personalized digital interactions. In the healthcare sector, Infibond focused on digital health applications, aiming to improve mental health monitoring, patient engagement, and personalized wellness programs. Despite raising over $100 million in funding, the company faced significant legal disputes and financial instability, leading to its closure and the liquidation of its assets in 2021.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Infibond.